MFDS Drug Approval Explained Simply: 2025 Compliance Plan for Pharma in South Korea South Korea’s MFDS Drug Approval Process 2025: Quick Guide for Regulatory Success Introduction to MFDS Regulatory Affairs and Its Importance The Ministry of Food and Drug Safety (MFDS), formerly known as the KFDA, is South Korea’s regulatory authority responsible for the evaluation and oversight of drugs, biologics, and medical devices. Its mission is to safeguard public health by ensuring that therapeutic products are safe, effective, and of high quality. South Korea is a rapidly growing pharmaceutical market, particularly in biologics, biosimilars, and advanced therapies, making MFDS approval…

Introduction to the MFDS: South Korea’s Drug Regulatory Authority – regulatory science Introduction to the MFDS: South Korea’s Drug Regulatory Authority This step-by-step tutorial provides pharmaceutical and clinical research professionals with a comprehensive understanding of the Ministry of Food and Drug Safety (MFDS) – South Korea’s regulatory authority. The focus is on navigating the regulatory framework of South Korea, covering essential areas such as dossier preparation, Good Manufacturing Practices (GMP), pharmacovigilance (PV), and approval timelines. This guide is relevant for professionals in regulatory affairs, quality assurance, and pharmacovigilance from the US, UK, EU, India, and around the globe. Step 1:…

Overview of the Pharmaceutical Regulatory Framework in South Korea – scientific regulatory affairs Overview of the Pharmaceutical Regulatory Framework in South Korea As pharmaceutical companies seek to enter the dynamic South Korean market, it is essential for regulatory affairs teams, quality assurance, pharmacovigilance, and other professionals to understand the intricate regulatory framework established by the Ministry of Food and Drug Safety (MFDS). This tutorial guide provides a detailed, step-by-step overview of the pharmaceutical regulatory landscape in South Korea, aimed at organizations seeking to navigate the complexities of scientific regulatory affairs effectively. Step 1: Understanding the Regulatory Authority and Legislative Framework…

Drug Approval Process: Step-by-Step Guide for New Drugs and Generics – regulatory affairs science Drug Approval Process: Step-by-Step Guide for New Drugs and Generics The drug approval process in South Korea, overseen by the Ministry of Food and Drug Safety (MFDS), is a complex and crucial journey involving multiple regulatory steps. This article aims to provide a comprehensive, step-by-step guide to navigating the drug approval process for both new drugs and generics, emphasizing practical actions, documentation needs, and compliance with local regulations. Step 1: Understanding the Regulatory Framework The first step in the drug approval process is to become familiar…

IND and NDA Filing Requirements for the MFDS – pv pharmacovigilance IND and NDA Filing Requirements for the MFDS: A Comprehensive Step-by-Step Guide Step 1: Understanding the Regulatory Framework of the MFDS In South Korea, the Ministry of Food and Drug Safety (MFDS) is the principal governing authority involved in the regulatory approval of pharmaceuticals. It oversees the Investigational New Drug (IND) and New Drug Application (NDA) processes, alongside ensuring compliance with Good Manufacturing Practices (GMP) and pharmacovigilance (pv). Grasping the regulatory landscape is essential for effective regulatory affairs management. The MFDS is guided by regulations established under the Pharmaceutical…

Understanding the Korean Common Technical Document (K-CTD) – regulatory affairs management Understanding the Korean Common Technical Document (K-CTD) for Regulatory Affairs Management Step 1: Familiarizing with the K-CTD Framework The Korean Common Technical Document (K-CTD) is a standardized organizational format implemented by the Ministry of Food and Drug Safety (MFDS) in South Korea for the submission of pharmaceutical products, including new drugs, generic drugs, and biologics. Understanding this framework is crucial for achieving compliance in regulatory affairs management. The K-CTD aligns with international standards set forth by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use…

Clinical Trial Authorization (CTA) Process and Local Study Requirements – regulatory audit Clinical Trial Authorization (CTA) Process and Local Study Requirements The Clinical Trial Authorization (CTA) process is a critical step in the regulatory framework for initiating clinical trials in South Korea. This step-by-step guide aims to provide regulatory affairs teams, quality assurance professionals, and healthcare regulatory consultants with an in-depth understanding of the CTA process, local study requirements, and practical actions needed for compliance. Step 1: Understanding the Regulatory Environment in South Korea Before initiating the CTA process, it is essential to have a comprehensive understanding of the regulatory…

GMP Certification Process and Inspection by the MFDS – healthcare regulatory consulting GMP Certification Process and Inspection by the MFDS In the biopharmaceutical landscape, understanding the regulatory framework is vital for organizations aiming to ensure compliance and market access. The Korean Ministry of Food and Drug Safety (MFDS) oversees the regulatory affairs related to pharmaceuticals, ensuring product safety and efficacy within the South Korean market. This step-by-step guide focuses on the Good Manufacturing Practice (GMP) certification process and inspection protocols established by the MFDS, providing crucial insights into navigating these requirements effectively. Step 1: Understanding GMP and Its Regulatory Importance…

Labeling, Leaflet, and Korean Translation Requirements – regulatory affairs and quality assurance Labeling, Leaflet, and Korean Translation Requirements in South Korea: A Regulatory Affairs Guide In the realm of regulatory affairs and quality assurance, especially concerning pharmaceutical products in South Korea, understanding the labeling, leaflet, and translation requirements is crucial for successful market access. The Ministry of Food and Drug Safety (MFDS) in South Korea mandates specific guidelines for drug labeling and packaging, ensuring compliance with both national and international regulations. This article serves as a comprehensive step-by-step tutorial for regulatory affairs professionals and quality assurance teams involved in the…

Post-Marketing Surveillance and Pharmacovigilance Reporting in Korea – quality assurance regulatory affairs Post-Marketing Surveillance and Pharmacovigilance Reporting in Korea The landscape of regulatory affairs is multifaceted, particularly in biotechnology and pharmaceutical companies. In South Korea, the Ministry of Food and Drug Safety (MFDS) oversees the stringent process of post-marketing surveillance (PMS) and pharmacovigilance (PV). This article serves as a comprehensive guide for regulatory affairs professionals, quality assurance teams, and pharmacovigilance specialists engaged in activities pertaining to quality assurance regulatory affairs. We will detail each critical step in the process of PMS and PV that is imperative for compliance and regulatory…